TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biogen (Denmark) A/S
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
34,827
|
41,353
|
34,921 |
Earnings before taxes |
1,440
|
1,464
|
1,412 |
Total assets |
26,644
|
21,562
|
32,699 |
Current assets |
26,532
|
21,379
|
32,585 |
Current liabilities |
7,952
|
3,970
|
16,224 |
Equity capital |
18,623
|
17,543
|
16,409 |
- share capital |
67
![]() |
67
![]() |
67 |
Employees (average) |
35
![]() |
35
![]() |
35 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
69.9%
|
81.4%
|
50.2% |
Turnover per employee |
995
|
1,182
|
998 |
Profit as a percentage of turnover |
4.1%
|
3.5%
|
4.0% |
Return on assets (ROA) | |||
Current ratio |
333.7%
|
538.5%
|
200.8% |
Return on equity (ROE) |
7.7%
|
8.3%
|
8.6% |
Change turnover |
-6,433
|
6,431
|
-5,878 |
Change turnover % |
-16%
|
18%
|
-14% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.